Riskpilot← Back to searchSign inGet full accessMona Wadefur AB
ABActiveOrg 5566137443Bryggaregatan 8 BGeneral medical practice activities · NACE 8621Est. 20011 employees
Revenue 2024
SEK 0
EBITDA margin
—
+30% vs 2023
Equity ratio
92.8%
Financial strength
Net profit 2024
SEK -102K
+67% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -21K | +30% |
| Net profit | SEK -102K | +67% |
| Total assets | SEK 553K | -15% |
| Equity | SEK 513K | -16% |
| Employees | 1 | — |
Legal name
Mona Wadefur AB
Org number
5566137443
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 augusti 2001
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till uppgift att bedriva allmänmedicinsk konsultverksamhet samt företagshälsovård inom hälso- och sjukvårdsbranschen. Verksamheten består också av handel med fast egendom, inventarier och utrustning för hälso- och sjukvård samt handel med och förvaltning av värdepapper och därmed förenlig verksamhet.
Address
Bryggaregatan 8 B
Email
mona.wadefur@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −185 | −191 | −104 | −30 | −21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −185 | −191 | −104 | −30 | −21 |
| Net financials | 22 | −167 | −1 147 | −557 | −165 |
| Profit before tax | 486 | 5 | −677 | −309 | −102 |
| Tax | −32 | −39 | −0 | −0 | −0 |
| Net profit | 454 | −34 | −677 | −309 | −102 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 890 | 1 689 | 960 | 654 | 553 |
| Equity | 1 634 | 1 600 | 923 | 614 | 513 |
| Long-term debt | 22 | 14 | 16 | 17 | 22 |
| Short-term debt | 52 | 74 | 21 | 23 | 19 |
| Total debt | 74 | 88 | 37 | 40 | 41 |
EBITDA margin
-2100000.0%
This company
15.8%
Market median
-13291239% vs market
20202024
Equity ratio
92.8%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
-19.9%
This company
18.4%
Market median
-208% vs market
20202024
Net profit margin
-10200000.0%
This company
8.1%
Market median
-125926026% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mona Wadefur AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gudrun Mona Lill-Anne Wadefur | Chief Executive Officer | 0 companies |
| Elis Kristofer Sell | Deputy Board Member | 0 companies |